Cystic Fibrosis (CF) profile, 32 mutations, DNA analysis
Cystic Fibrosis (CF) profile, 32 mutations, DNA analysis-14545
This test has been discontinued. To order a referred alternate, place an MSO order for LabCorp 482632 Cystic Fibrosis (CF) Full-gene Carrier Screen
G85E; ΔI507; R553X; 711+1G>T; 3659delC; R117H; ΔF508; R560T; 1078delT; 3849+10kbC>T; V520F; R1162X; 1717-1G>A; 3876delA; R334W; G542X; W1282X; 1898+1G>A; 3905insT; R347P; S549N; N1303K; 2183AA>G; 2184delA; R347H; S549R; 394delTT; 2789+5G>A; A455E; G551D; 621+1G>T; 3120+1G>A
Help determine affected or carrier status for the 32 most common CF mutations
This assay detects as many as 90% of cystic fibrosis carriers in the Caucasian population. Within other ethnic groups, there may be higher or lower detection efficiency. Includes the mutation profile currently recommended by the ACMG and the ACOG.
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting
Whole blood tube should be sent to the lab unopened.
It is preferable not to perform additional testing on original tubes prior to PCR testing.
Yellow ACD (A or B)
Yellow ACD (A or B)
Provider must fill out screening questionnaire and send to the lab collecting the patient’s specimen.
Ambient (preferred) - 14 days
Frozen - NO
- Frozen specimen
- Hemolysis
- Quantity not sufficient for analysis (QNS)
- Improper container
Polymerase chain reaction (PCR); primer extension; flow-sorted bead array analysis
An interpretive report will be provided
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.
- Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
- All information requested is required in order for your request to be completed